Get Live Data
Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Destiny Pharma. Share Price
  4. Destiny Pharma. Share Regulatory News
  5. Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections

Pin to quick picksDestiny Pharma. Regulatory News (DEST)

Destiny Pharma. Information

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.25
Bid: 10.00
Ask: 10.50
Change: -0.75 (-6.82%)
Spread: 0.50 (5.00%)
Open: 11.00
High: 11.00
Low: 10.25
Prev. Close: 11.00
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections

21 Nov 2022 14:20

Destiny Pharma PLC Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections 21.11.2022 / 15:19 CET/CEST The issuer is solely responsible for the content of this announcement.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

21.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language:English
Company:Destiny Pharma PLC
United States
ISIN:GB00BDHSP575
EQS News ID:1492837
 
End of NewsEQS News Service

1492837 21.11.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

12345
Date   Source Headline
4th Nov 20217:00 amRNSSAB Member Prof. Gerding is Keynote at C.diff Conf
18th Oct 20217:00 amRNSStudy gives strong support for potential of XF-73
27th Sep 20213:18 pmRNSDirector/PDMR Shareholding
27th Sep 20217:00 amRNSExpansion of clinical pipeline
9th Sep 20217:00 amRNSInterim results for six months ended 30 June 2021
23rd Aug 20217:00 amRNSNotice of Interim Results
2nd Aug 20217:00 amRNSSecondary endpoint analysis from Phase 2b trial
9th Jul 20218:00 amRNSXF-73 Phase 2b data to be presented at ECCMID
6th Jul 20217:00 amRNSNTCD-M3 RD Agreement with US Dept Veterans Affairs
2nd Jul 20218:00 amRNSScientific Advisor Gerding chairs C Diff symposium
29th Jun 20218:24 amRNSDEST to present at Shares & AJ Bell Webinar 6/7/21
10th Jun 20215:00 pmRNSDirector Dealing
10th Jun 20217:00 amRNSXF-73 data abstract to be presented at 2021 ECCMID
7th Jun 20217:00 amRNSDestiny Pharma welcomes G7’s Communique on AMR
3rd Jun 202112:03 pmRNSResult of AGM
2nd Jun 20217:00 amRNSPositive update on microbiome therapeutic NTCD-M3
25th May 20217:00 amRNSFurther information re AGM
19th May 20217:00 amRNSNotice to Register for 2021 AGM
6th May 202110:00 amRNSConference Attendance for May 2021
4th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20217:00 amRNSDirector Dealing
23rd Apr 20217:00 amRNSDirector Dealing
15th Apr 20218:00 amRNSFY 2020 Investor Presentation
14th Apr 20217:00 amRNSFinal Results
29th Mar 202112:45 pmRNSExercise of Options and Total Voting Rights
29th Mar 202112:00 pmRNSDestiny Pharma to Join Equity Development Webinar
29th Mar 202111:06 amRNSSecond Price Monitoring Extn
29th Mar 202111:00 amRNSPrice Monitoring Extension
29th Mar 202110:15 amRNSExercise of Options and Total Voting Rights
29th Mar 20219:06 amRNSSecond Price Monitoring Extn
29th Mar 20219:00 amRNSPrice Monitoring Extension
29th Mar 20217:00 amRNSDestiny Pharma Reports Positive Phase 2b Results
16th Mar 20217:00 amRNSNotice of Results
15th Mar 20217:00 amRNSDestiny Pharma Announces Agreement with NIAID
10th Mar 20212:15 pmRNSExercise of Options and Total Voting Rights
10th Mar 20217:00 amRNSDestiny Pharma CSO Joins UKRI COVID-19 Taskforce
10th Feb 20212:05 pmRNSSecond Price Monitoring Extn
10th Feb 20212:00 pmRNSPrice Monitoring Extension
3rd Feb 20217:00 amRNSBrazilian Patent Granted for XF-73 nasal gel
2nd Feb 20217:05 amRNSDestiny Pharma to join panel discussion at LSX
2nd Feb 20217:00 amRNSDestiny Pharma Appoints Professor Mark Wilcox
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20214:31 pmRNSGrant of Share Options
21st Jan 20218:28 amRNSDestiny Pharma Investor Presentation
14th Jan 202111:05 amRNSSecond Price Monitoring Extn
14th Jan 202111:00 amRNSPrice Monitoring Extension
7th Jan 202111:05 amRNSSecond Price Monitoring Extn
7th Jan 202111:00 amRNSPrice Monitoring Extension
7th Jan 20217:00 amRNSDestiny Pharma: Directors Dealings
12345

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.